Skip to main content
Clinical Trials/NCT02882399
NCT02882399CompletedPhase 2

Shortystrap Effectiveness in the Treatment of the Pathology Pubic and Abdominal Pathology in Athletes

Rennes University Hospital1 site in 1 country49 target enrollmentStarted: April 12, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
49
Locations
1
Primary Endpoint
Evaluation of pain using a scale Feretti

Study Overview

Brief Summary

The pubic and abdominal pathology is common among athletes. It leads to a shutdown of physical activity for several months, and requires rehabilitative care, or surgery for a permanent cure. Shortystrap is designed to avoid surgery and allow the continuation of sports.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Sports practicing physical activity at least 3 hours per week
  • Practicing a team sport with a major part of running (football, rugby, ...)
  • Presenting a pubic and abdominal pathology for at least 4 weeks
  • In primary consultation
  • Age from 18 to 40 years
  • Informed consent signed

Exclusion Criteria

  • Professional athlete
  • Having already received usual medical treatment (anti-inflammatory treatment and rest)
  • Introducing another disease requiring treatment with NSAIDs
  • Allergy neoprene
  • Contraindications to performing MRI (claustrophobia, any metal device, pacemaker, etc.)
  • Simultaneous participation in another biomedical research
  • Major person under legal protection (backup justice, trusteeship, guardianship), person deprived of liberty.

Arms & Interventions

Shortystrap

Experimental

Intervention: Shortystrap (Other)

Outcomes

Primary Outcomes

Evaluation of pain using a scale Feretti

Time Frame: Day 15

scale Feretti

Secondary Outcomes

  • Evaluation of pain using a visual analog scale(Day 15, Day 30 and Day 60)

Investigators

Sponsor
Rennes University Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials